Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/26 16:38 | 8/18/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 5 | S.d | -1,367 | 78.10 | 0 | -18 | 154 | D | |||||||||||||||
8/10/26 17:11 | 8/10/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Blum Robert I | CA | DO | P,CEO | 6 | S.d | -3,542 | 78.71 | 0 | -45 | 397 | D | |||||||||||||||
7/30/26 16:26 | 7/30/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | 3 | S.d | -3,517 | 79.92 | 0 | -44 | 59 | D | |||||||||||||||
7/2/26 17:17 | 7/1/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Lee Sung | CA | O | EVP,CFO | 3 | S.d | -3,551 | 82.64 | 0 | -43 | 63 | D | |||||||||||||||
6/1/26 18:54 | 6/1/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Kaye Edward M. Md | CA | D | 1 | S | -223 | 76.09 | 0 | -3 | 10 | D | ||||||||||||||||
6/1/26 18:49 | 6/1/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Parshall B Lynne | CA | D | 1 | S | -370 | 74.08 | 0 | -5 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |